Añadido el 22/01/2017

Puntos clave de aprendizaje

  • Abordaje quirúrgico para la resección del feocromocitoma
  • Antagonistas α-1 selectivos en feocromocitoma
  • Cuándo realizar una biopsia de una masa suprarrenal
  • Diagnóstico del feocromocitoma
  • Evaluación y manejo postoperatorio del paciente con feocromocitoma
  • Feocromocitoma: definición y manifestaciones clínicas
  • Neurofibromatosis tipo 1
  • Preparación preoperatoria para la resección quirúrgica de un feocromocitoma
  • Pruebas de imagen de un feocromocitoma sospechoso
  • Resonancia Magnética de un feocromocitoma sospechoso
  • Seguimiento postoperatorio del paciente con feocromocitoma
  • Síndrome de Von Hippel-Lindau
  • TC de un feocromocitoma sospechoso
  • Tratamiento médico preoperatorio para feocromocitoma
  • Técnicas de anestesia para la resección del feocromocitoma
  • fenoxibenzamina: uso en feocromocitoma y efectos secundarios
  • neoplasia endocrina múltiple tipo 2 (MEN2)


1. ZUBER SM, KANTOROVICH V, PACAK K. Hypertension in Pheochromocytoma: Characteristics and Treatment Endocrinol Metab Clin North Am [online] 2011 Jun, 40(2):295-311 [viewed 10 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094542
2. GUéRIN M, GUILLEMOT J, THOUëNNON E, PIERRE A, EL-YAMANI FZ, MONTERO-HADJADJE M, DUBESSY C, MAGOUL R, LIHRMANN I, ANOUAR Y, YON L. Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma. Regul Pept [online] 2010 Nov 30, 165(1):21-9 [viewed 10 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/20600356
3. DäRR R, LENDERS JW, HOFBAUER LC, NAUMANN B, BORNSTEIN SR, EISENHOFER G. Pheochromocytoma - update on disease management Ther Adv Endocrinol Metab [online] 2012 Feb, 3(1):11-26 [viewed 10 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474647
4. CHEN H, SIPPEL RS, PACAK K. The NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Pheochromocytoma, Paraganglioma & Medullary Thyroid Cancer Pancreas [online] 2010 Aug, 39(6):775-783 [viewed 10 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419007
5. SAWKA AM, JAESCHKE R, SINGH RJ, YOUNG WF JR. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab [online] 2003 Feb, 88(2):553-8 [viewed 10 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/12574179
6. JALIL ND, PATTOU FN, COMBEMALE F, CHAPUIS Y, HENRY JF, PEIX JL, PROYE CA. Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 cases. French Association of Surgery (AFC), and The French Association of Endocrine Surgeons (AFCE). Eur J Surg [online] 1998 Jan, 164(1):23-8 [viewed 13 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/9537705
7. BESSELL-BROWNE R, O'MALLEY ME. CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of nonionic contrast material. AJR Am J Roentgenol [online] 2007 Apr, 188(4):970-4 [viewed 13 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/17377032
8. BAJWA SS, BAJWA SK. Implications and considerations during pheochromocytoma resection: A challenge to the anesthesiologist Indian J Endocrinol Metab [online] 2011 Oct, 15(Suppl4):S337-S344 [viewed 13 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230104
9. GARG MK, KHARB S, BRAR KS, GUNDGURTHI A, MITTAL R. Medical management of pheochromocytoma: Role of the endocrinologist Indian J Endocrinol Metab [online] 2011 Oct, 15(Suppl4):S329-S336 [viewed 13 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230088
10. SCHMEDTJE JF JR, SAX S, POOL JL, GOLDFARB RA, NELSON EB. Localization of ectopic pheochromocytomas by magnetic resonance imaging. Am J Med [online] 1987 Oct, 83(4):770-2 [viewed 13 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/3674064
11. MAUREA S, CUOCOLO A, REYNOLDS JC, NEUMANN RD, SALVATORE M. Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison. Q J Nucl Med [online] 1996 Dec, 40(4):365-71 [viewed 13 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/9050342
12. BLAKE MA, KALRA MK, MAHER MM, SAHANI DV, SWEENEY AT, MUELLER PR, HAHN PF, BOLAND GW. Pheochromocytoma: an imaging chameleon. Radiographics [online] 2004 Oct:S87-99 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/15486252
13. MAHER ER, NEUMANN HP, RICHARD S. von Hippel-Lindau disease: A clinical and scientific review Eur J Hum Genet [online] 2011 Mar 9, 19(6):617-623 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110036
14. FRIEDRICH CA. Von Hippel-Lindau syndrome. A pleomorphic condition. Cancer [online] 1999 Dec 1, 86(11 Suppl):2478-82 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/10630173
15. GUT P, KOMAROWSKA H, CZARNYWOJTEK A, WALIGóRSKA-STACHURA J, BąCZYK M, ZIEMNICKA K, FISCHBACH J, WROTKOWSKA E, RUCHAłA M. Familial syndromes associated with neuroendocrine tumours Contemp Oncol (Pozn) [online] 2015 Jul 8, 19(3):176-183 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631294
16. MOLINE J, ENG C. Multiple endocrine neoplasia type 2: an overview. Genet Med [online] 2011 Sep, 13(9):755-64 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/21552134
17. RAUE F, ZINK A. Clinical features of multiple endocrine neoplasia type 1 and type 2. Horm Res [online] 1992:31-5 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/1363414
18. LENDERS JW, DUH QY, EISENHOFER G, GIMENEZ-ROQUEPLO AP, GREBE SK, MURAD MH, NARUSE M, PACAK K, YOUNG WF JR, ENDOCRINE SOCIETY. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab [online] 2014 Jun, 99(6):1915-42 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/24893135
19. PRYS-ROBERTS C, FARNDON JR. Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J Surg [online] 2002 Aug, 26(8):1037-42 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/12192533
20. VANDERVEEN KA, THOMPSON SM, CALLSTROM MR, YOUNG WF JR, GRANT CS, FARLEY DR, RICHARDS ML, THOMPSON GB. Biopsy of pheochromocytomas and paragangliomas: potential for disaster. Surgery [online] 2009 Dec, 146(6):1158-66 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/19958944
21. WISEMAN GA, PACAK K, O'DORISIO MS, NEUMANN DR, WAXMAN AD, MANKOFF DA, HEIBA SI, SERAFINI AN, TUMEH SS, KHUTORYANSKY N, JACOBSON AF. Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial. J Nucl Med [online] 2009 Sep, 50(9):1448-54 [viewed 14 July 2016] Available from: http://www.ncbi.nlm.nih.gov/pubmed/19690028